Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00501618 · ClinicalTrials.gov registry record · Phase 4
Equivalence of Generic Clozapine to Orally Dissolving Clozapine in Schizophrenia or Schizoaffective Disorder
A Phase 4 study, sponsored by Manhattan Psychiatric Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
NCT00501618 is a Phase 4 study that has completed, run by Manhattan Psychiatric Center. The registered enrollment target is 20 participants.
The verdict
NCT00501618, a Phase 4 study, has completed, sponsored by Manhattan Psychiatric Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to obtain data on equivalence of generic clozapine to Fazaclo (orally disintegrating tablet). Generic clozapine is the most frequently used clozapine and such data is important for clinicians to have.
Interventions
- DRUG Fazaclo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2006-11 |
| Est. Completion | 2009-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00501618
The ClinicalTrials.gov registry entry for NCT00501618 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Manhattan Psychiatric Center, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Fazaclo is the first listed.
NCT00501618 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00501618 about?
NCT00501618 is a clinical study titled "Equivalence of Generic Clozapine to Orally Dissolving Clozapine in Schizophrenia or Schizoaffective Disorder". The purpose of this study is to obtain data on equivalence of generic clozapine to Fazaclo (orally disintegrating tablet). Generic clozapine is the most frequently used clozapine and such data is important for clinicians to have.
What is the current status of trial NCT00501618?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2006-11. Estimated completion is 2009-07.
What interventions are being tested in trial NCT00501618?
The interventions under investigation include: Fazaclo (DRUG).
Who is sponsoring clinical trial NCT00501618?
This trial is sponsored by Manhattan Psychiatric Center, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.